Member Exclusive News

The week in industry: New Drug Discovery Advisory Network established

Vertex Pharmaceuticals and Semma Therapeutics (both MA, USA) join to produce novel diabetes treatment, Processa Pharmaceuticals (MD, USA) to develop anti-fibrotic and muscular regeneration drug, breakthrough designation given to respiratory syncytial virus vaccine.

Go to the profile of RxNet
Sep 06, 2019

Please sign in or register for FREE

No comments yet.